Correcting human mitochondrial mutations with targeted RNA import.

Area of Science:

• Mitochondrial biology
• Molecular genetics
• RNA therapeutics

Background:

• Mitochondrial DNA mutations cause various diseases, including neuromuscular disorders and metabolic defects.
• Current methods for correcting mitochondrial genetic defects are limited.
• Targeting RNA to mitochondria is crucial for therapeutic interventions.

Purpose of the Study:

• To develop an efficient method for targeting RNA molecules into human mitochondria.
• To investigate the role of specific RNA sequences and cellular machinery in mitochondrial RNA import.
• To demonstrate the therapeutic potential of this approach in disease models.

Main Methods:

• Appending a 20-ribonucleotide stem-loop sequence from H1 RNA to various RNA transcripts.
• Utilizing polynucleotide phosphorylase (PNPASE) for RNA import into mitochondria.
• Investigating the necessity of 3'-untranslated region (UTR) sequences for mitochondrial import of different RNA types.
• Assessing the functional rescue of mitochondrial defects in human disease cell lines.

Main Results:

• Successfully imported fusion transcripts (including tRNAs and mRNAs) into human mitochondria.
• Demonstrated that PNPASE facilitates RNA import.
• Identified that 3'-UTR sequences are essential for importing certain mitochondrial-encoded tRNAs but not all mRNAs.
• Reversed defects in mitochondrial RNA translation and cell respiration in disease models.

Conclusions:

• A novel RNA targeting strategy using a specific stem-loop sequence enables efficient mitochondrial import.
• This method is versatile for various RNA types and can be modulated by localization sequences.
• This approach provides a promising general strategy for addressing mitochondrial genetic disorders.